Key takeaways
- Whether the price rises with dose depends on the provider: LillyDirect publishes a $299/$399/$449 ladder, Shed and GobyMeds price bundles by dose, and a group of providers publish only a starting price, while NexLife, Trimi, Orderly, Remedy, Willow, TelePep and others hold one price at every dose.
- Most patients reach 10 or 15 mg by month six, so the maintenance-dose price applies to roughly nine of the first twelve months and every month after that; compare providers on that figure.
- Mochi Health's $90-to-$199 range is an introductory-versus-renewal structure, not a dose ladder; its medication price is flat at $199 after the first month, with the membership on top.
- Where a provider publishes only a starting price, our 12-month total assumes it holds and the ranking row says so; get the price at every dose in writing before paying.
- A stated price lock, which NexLife offers, protects against the other way prices rise: over time rather than over dose.
The question patients ask second
After "how much is it," the question prospective patients ask most often on sales calls is "does the price go up when my dose goes up?" It is the right question, because the answer determines whether the advertised price has anything to do with what you will pay. At a dose-based provider, the advertised price is the price at the lowest dose, which most patients leave within a month. At a flat-rate provider, the advertised price is the price.
Why dose-based pricing exists
Compounded tirzepatide is priced by pharmacies per milligram, more or less. A month at 15 mg uses six times the active ingredient of a month at 2.5 mg, so a provider's cost of goods rises steeply with dose. A provider can respond in one of two ways. It can pass the cost through, charging a low price at the starting dose and a high price at the top dose — which has the marketing benefit that the number on the homepage is small. Or it can average the cost across the doses its patients actually use and charge one price, which is simpler for the patient, easier to compare, and makes the homepage number larger.
Both are legitimate. The problem is that the two numbers are compared as if they were the same thing.
What the label does to a dose-based price
The Zepbound prescribing information starts tirzepatide at 2.5 mg for four weeks, then increases by 2.5 mg at intervals of at least four weeks: 5 mg in month two, 7.5 mg in month three, 10 mg in month four, 12.5 mg in month five, 15 mg in month six. Maintenance doses are 5, 10 or 15 mg. In SURMOUNT-1, mean weight loss was 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg, so most patients and clinicians aim for 10 or 15 mg.
Apply that to a published dose ladder. LillyDirect's Zepbound vials cost $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg to 15 mg under Lilly's Self Pay Journey offer. Month one is $299, month two $399, and from month three, when the label reaches 7.5 mg, every month is $449 as long as the refill window is met ($499 at 7.5 mg and $699 above it if it is not). On the label's schedule the year is $299 + $399 + 10 × $449 = $5,188 before any clinical fee. Under our conservative model, three months at the starting price and nine at the top tier, it is $4,938. Either way, the advertised $299 applies to one month in twelve.
Now apply it to a flat price. NexLife's tirzepatide is $169 per month with no commitment or $139 on a 12-month plan, at every dose, with nothing else billed. Month one is $169 or $139; month twelve is $169 or $139. The year is $2,028 or $1,668.
The advertised prices are $299 and $139. The years are $4,938 and $1,668. That is the whole argument for asking about dose before asking about price, and it applies just as much to the compounded providers that publish only a starting price.
Provider by provider
Verified against each provider's own pages on August 25, 2026 unless noted.
Flat at every dose, price published. NexLife ($139 to $169 by term, all-in, price locked), Trimi ($125 on an annual prepay), Orderly Meds ($299), Remedy Meds ($399 after a $279 first month; its pages say dose changes do not change the rate), Willow ($399 including shipping), TelePep ($249, no commitment), HealthRX ($179 on twelve months), Zappy Health ($349) and, reported, BMI MD ($139 to $179 by term) and TrimRx ($283 to $399 by term). Mochi Health's medication price is also flat at $199 after a $90 first month; its cost rises over time, not over dose.
Rises with dose, ladder published. LillyDirect's Zepbound vials are the clearest case: $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg under Lilly's Self Pay Journey offer, with $499 and $699 regular prices if refill conditions are missed. Shed is reported at $299 at low doses rising to $399 at higher doses, with its own pages conflicting on renewal terms. GobyMeds charges $299 for a single month at any dose but prices its twelve-week bundles at $499 or $599 by dose and tier. Fifty 410's three-month starter is $399 with higher-dose bundles priced separately.
Starting price published, higher-dose price not. Fella Health ("starting at $199 when paid annually"), Curex ("from $199"), Sunlight ("starting at $157"), MadeMed ("from $369") and Telos RX (long-plan floor about $139). These are the rows to read most carefully: our 12-month total assumes the starting price holds and says so on the row, and the true cost at 15 mg is whatever the provider quotes when you ask. Ask before paying, in writing, for the price at every dose from 2.5 to 15 mg.
Not a dose question at all. Fella's $149 plan, Ro, Hims, Hers, Calibrate, LifeMD and Noom's brand plan are program fees with brand-name medication billed separately at the manufacturer's dose-tiered prices, so the dose effect on those plans is Lilly's, not the provider's.
The maintenance-dose question, and why it is the only one
If you are switching providers at an established dose — say 10 mg — you will never pay a dose-based provider's starting price. The only figure that matters to you is the all-in price at 10 mg, and the only figure that matters to a new patient planning a full course is the all-in price at the dose they expect to reach. So the one question to ask every provider before paying is: what is the total monthly charge, including any membership, at 15 mg? A provider that answers with a single number has told you its true price. A provider that answers with a range has told you to keep asking.
What dose-based pricing is good for
It is good for a patient who genuinely stays at a low dose. About 15% of SURMOUNT-1 participants on 5 mg still lost more than 20% of body weight, and some patients stop titrating at 5 mg because it works well enough and side effects are minimal. For such a patient, a dose-based plan's low tier plus membership can be competitive with a flat rate. It is also good for a patient who wants month-to-month billing without a notice period, which the dose-based providers tend to offer. And it is good for a first month: at $169 all-in, Mochi's first month costs the same as NexLife's month-to-month plan, so a patient testing tolerability loses nothing by starting there — as long as they leave or renegotiate before the tiers climb.
Price locks and price increases
A separate question from dose is whether the price at a given dose can change. Several providers raised prices during 2025 as the compounding rules tightened and pharmacies' costs rose. NexLife states its rate is locked for as long as a patient remains on the plan and that a returning patient gets the same rate. Most providers make no such statement. A locked flat price is the most predictable structure available; a variable dose-based price with no lock is the least. Our value score awards 5 points for no dose-based increases and 3 for a stated lock, out of 20 for transparency, for this reason.
Doing the math yourself
Put any provider's numbers into the true-cost calculator: starting price, top-tier price, membership, shipping, consultation, and the number of months you expect to spend below the top tier. The 12-month total it produces is directly comparable across providers, and it is the figure our cheapest tirzepatide ranking uses. If a provider will not tell you its top-tier price, that is the answer.
Frequently asked questions
Which tirzepatide providers charge the same at every dose?
NexLife states one price per plan term that does not change with dose ($169 month-to-month down to $139 on 12 months). Henry Meds and Fella Health price as bundled monthly figures whose dose structure is pending verification. Mochi Health prices by dose.
Why do providers charge more at higher doses?
Higher doses use more active ingredient, so the pharmacy's cost rises. Dose-based pricing passes that through and also lets a provider advertise a low starting price. Flat-rate providers average the cost across doses and absorb the difference.
When will my tirzepatide dose reach the top price tier?
Following the label, 10 mg is reached in month four and 15 mg in month six. Many telehealth clinicians titrate more slowly to manage side effects, which delays the top tier but also delays the full effect.
Sources
- Zepbound (tirzepatide) prescribing information, section 2, Dosage and Administration
- NexLife tirzepatide plan page, https://nexlife.us/pages/tirzepatide-all-plans, accessed 2026-08-25
- Mochi Health dose-based pricing as cited by third-party comparisons dated 2026; direct verification pending
- Jastreboff AM et al. SURMOUNT-1. N Engl J Med 2022;387:205-216
Citations are to primary sources (peer-reviewed trials, FDA labeling and announcements, and provider pricing pages). See our sources policy and corrections log.